Summary of Oscar Health's Q2 2026 Earnings Call

1Key Financial Results and Metrics

Revenue: $4.9 billion, up 70% year-over-year.

Net Income: $1 billion for the first half of 2026; $362 million for Q2, a $590 million increase year-over-year.

Earnings from Operations: $389 million in Q2, a $619 million improvement year-over-year.

Medical Loss Ratio (MLR): Improved to 79.2%, a 12-point year-over-year improvement.

SG&A Expense Ratio: Reached a record low of 14.2%, a 450 basis point improvement year-over-year.

Membership: Ended Q2 with 2.96 million members, a 46% increase year-over-year.

2Strategic Updates and Business Highlights

Oscar is focusing on the individual market, emphasizing the importance of portable coverage for gig workers and part-time employees.

The company is leveraging AI across various operations, achieving a claims processing accuracy of 98.7% and processing most claims within 48 hours.

A new radiology program was piloted, enhancing member experience and cost management.

Continued growth in Individual Coverage Health Reimbursement Arrangements (ICHRA) is noted, with partnerships enhancing capabilities.

The company is committed to reducing friction in healthcare access through innovative product offerings.

3Forward Guidance and Outlook

Full-year earnings from operations guidance raised to $500 million to $700 million, an increase of $250 million from prior estimates.

Total revenue expected to be between $18.7 billion and $19 billion.

Anticipated MLR for the full year adjusted to 81.5% to 82.5%.

SG&A expense ratio guidance improved to 15.6% to 16.1%.

The company expects increasing membership churn in the second half of the year, potentially doubling previous estimates of 1% to 2%.

4Bad News, Challenges, or Points of Concern

Total ACA membership declined by 12% year-over-year, although Oscar's membership growth remains strong.

Potential risks from CMS program integrity efforts could lead to increased disenrollments in the second half of the year, particularly affecting members in Florida and Texas.

The company is cautious about future market conditions and pricing strategies, especially with the anticipated rational pricing environment in 2027.

There is a noted concern regarding the impact of higher deductibles on member utilization patterns.

5Notable Q&A Insights

Management acknowledged elevated outpatient utilization but emphasized stability across other categories.

Discussions highlighted the impact of AI on transitioning employment patterns and the potential for ICHRA to capture market share.

Clarifications were provided on risk adjustment processes, with management expressing confidence in the stability of their current membership and pricing strategies.

The company is actively reviewing CMS's eligibility verification lists and believes that the financial implications of potential disenrollments are accounted for in their guidance.

Management indicated that the IDR process is not a significant trend driver for Oscar, positioning it as a manageable aspect of their operations. Overall, Oscar Health reported strong financial performance in Q2 2026, with significant year-over-year improvements across key metrics, while also navigating challenges related to market dynamics and regulatory changes. The company remains optimistic about its strategic initiatives and long-term growth potential.